[ DB08904 ] . DB08904 is a new anti- P01375 drug formed by the Fab ' fragment of a humanized mouse monoclonal antibody bound to two molecules of polyethylene glycol . DB08904 recognizes and binds to human P01375 -Î± , both in its soluble and membrane bound form , and has shown clinical efficacy in controlled trials for the treatment of RA and Crohns ' disease . In this review we summarize the structural characteristics and clinical efficacy data , as well as safety data of this anti- P01375 agent in patients with RA .